Browse drugs

… and clinicians in proactive surveillance of patients receiving dolutegravir. Prospective validation and workflow integration will be requir…

…ain characteristics of 2359 PWH enrolled in the Bictegravir and Dolutegravir SCOLTA cohortsAbstract P20 Table 2Reasons for 568 discontinuati…

…te (TDF) (300 mg daily) plus lamivudine (3TC) (300 mg daily) or DTG (50 mg daily) in combination with TDF (300 mg once daily) plus …

…ctegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) vs. dolutegravir (DTG)-based single tablet regimens (STR) on treatment failure-r…

… comparable in subjects treated with DOR/3TC/TDF, BIC/F/TAF, or DOL/3TC.Conclusions In our study, initial antiretroviral regimen with D…

… HCV-coinfection, no significant differences were found between DTG and TAF group as regards weight, BMI and lipid profile (see tab…

…birth, accounting for transplacental DTG exposure and alongside zidovudine postnatal prophylaxis. DTG plasma concentrations at 6–10 days s…

… strand transfer inhibitor (INSTI)-based regimens, particularly dolutegravir- and bictegravir-containing combinations, increased steadily, w…

…oduction Since July 2019, the WHO has recommended dolutegravir (DTG)-based regimens as preferred first-line antiretroviral therapy …